Steven Marc Paul, M.D., is Executive Vice President of Science and Technology and President of the Lilly Research Laboratories (LRL) of Eli Lilly and Company.  Dr. Paul joined Lilly in April of 1993, initially as a Vice President of the Lilly Research Laboratories responsible for Central Nervous System (CNS) Discovery and Decision Phase Medical Research.  In 1996, Dr. Paul was appointed Vice President (and in 1998 Group Vice President) of Therapeutic Area Discovery Research and Clinical Investigation.  In 2003, Dr. Paul was named Executive Vice President of the Company and President of LRL with responsibility for all research and development at Lilly.  In 2005, Dr. Paul was named Chief Scientific Officer of the Year as one of the Annual Pharmaceutical Achievement Awards.  Prior to assuming his position at Lilly, Dr. Paul served as Scientific Director of the National Institute of Mental Health (NIMH/NIH) in Bethesda, Maryland.

Dr. Paul received his Bachelor of Arts degree, Magna Cum Laude with honors in Biology and Psychology from Tulane University, in 1972.  He received his Master of Science degree in Anatomy (Neuroanatomy) and his Doctor of Medicine degree, both in 1975, from the Tulane University School of Medicine.  He subsequently served as a resident in Psychiatry and an Instructor in the Department of Psychiatry at the University of Chicago, Pritzker School of Medicine.  In 1976, he was awarded a research fellowship in the Pharmacology Research Associate Training Program of the National Institute of General Medical Science (NIGMS), to work with Nobel Laureate Dr. Julius Axelrod in the Laboratory of Clinical Science, IRP, of the NIMH.

Dr. Paul is a member of various professional and honorary societies, which include Phi Eta Sigma; Alpha Epsilon Delta; Sigma Xi; Phi Beta Kappa; and the Alpha Omega Alpha Honorary Medical Society.  He is the recipient of the A. E. Bennett Award of the Society of Biological Psychiatry; the Arthur S. Flemming Award by the Downtown Jaycees (outstanding research by a government employee); the Allan C. Davis Medal (Outstanding Young Scientist Award) of the Maryland Academy of Sciences; the Foundations' Fund Prize for Research of the American Psychiatric Association, the Daniel H. Efron Award of the ACNP; the Max Hamilton Award of the CINP; the Distinguished Service Medal of the USPHS and the Chief Scientific Officer of the Year Award.  In 1997, Dr. Paul was elected to membership in the Institute of Medicine of the National Academy of Sciences and served on its Board of Neuroscience and Behavior (1998-2001).

Dr. Paul also served as Medical Director in the Commissioned Corps of the United States Public Health Service.  He is Board Certified by the American Board of Psychiatry and Neurology and has been elected a Fellow in the American College of Neuropsychopharmacology (ACNP), served on the ACNP Council and was elected President of the ACNP (1999).  Dr. Paul served as a member of the National Advisory General Medical Sciences Council, NIH (1996-1999), and was appointed by the Secretary of HHS to serve as a member of the Advisory Committee to the Director of NIH (2001-2006).  Dr. Paul serves as chairperson of PhRMA’s Science and Regulatory Committee and on the board of BIO.  He also currently serves on the boards of the NIH Foundation, the Lilly Foundation, Butler University, Indianapolis Zoological Society and the Sigma-Aldrich Corporation.

<< Back